ENTITY
Dr. Reddy's Laboratories

Dr. Reddy's Laboratories (DRRD IN)

210
Analysis
Health Care • India
Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company also manufactures and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The Company markets its products in India and around the world.
more
•08 Mar 2019 11:33

India Generic Drugs: "Antitrust Unredacted"

New information in the government's investigation into antitrust violations by generic drug companies continues to surface. An unredacted version...

Share
bearish•Cross Asset Strategy
•01 Apr 2025 09:51

Asian Alpha Hedge Fund (AAHF): INTRODUCTION

Asian Alpha Hedge Fund (AAHF) returned 32% in the first quarter of 2025.  The fund outperformed the MSCI All Country Asia Pacific index by 28%. ...

Logo
140 Views
Share
bearish•Aurobindo Pharma
•01 Jan 2019 22:29

India Generic Drugs: Antitrust Suit Could Cost Billions

This Insight builds on our previous Insight, India Generic Drugs: US Antitrust Inquiry Widens by discussing estimated potential liabilities and...

Share
•22 Dec 2018 06:01

EM Relative Strength Is Bottoming: Overweight

Relative strength for MSCI EM is bottoming vs. MSCI EAFE despite continued global equity market weakness.  Although the MSCI EM's price index...

Logo
1.2k Views
Share
bearish•MSCI ACWI Index
•20 Dec 2018 22:08

Global Markets Deteriorating...Except EM

With U.S. markets stumbling, the MSCI ACWI index is breaking down to new lows: defensive Sectors remain attractive. Relative to MSCI ACWI however,...

Logo
1k Views
Share
x